The triglyceride–high-density lipoprotein axis: An important target of therapy?

This publication has 63 references indexed in Scilit:

• Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR * Trial)
  Published by Elsevier ,2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Effect of combined fluvastatin-fenofibrate therapy compared with fenofibrate monotherapy in severe primary hypercholesterolemia
  The American Journal of Cardiology, 2000
• Statin + fibrate combination therapy: Fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease
  International Journal of Cardiology, 1999
• Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
  The American Journal of Cardiology, 1996
• Effects of pravastatin with niacin or magnesium on lipid levels and postprandial lipemia
  The American Journal of Cardiology, 1995
• Fluvastatin with and without niacin for hypercholesterolemia
  The American Journal of Cardiology, 1994
• Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia
  The American Journal of Cardiology, 1994
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987